JP2022513164A5 - - Google Patents
Info
- Publication number
- JP2022513164A5 JP2022513164A5 JP2021531011A JP2021531011A JP2022513164A5 JP 2022513164 A5 JP2022513164 A5 JP 2022513164A5 JP 2021531011 A JP2021531011 A JP 2021531011A JP 2021531011 A JP2021531011 A JP 2021531011A JP 2022513164 A5 JP2022513164 A5 JP 2022513164A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- cell
- peripheral blood
- blood mononuclear
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774142P | 2018-11-30 | 2018-11-30 | |
| US62/774,142 | 2018-11-30 | ||
| US201962878736P | 2019-07-25 | 2019-07-25 | |
| US62/878,736 | 2019-07-25 | ||
| PCT/US2019/064074 WO2020113234A1 (en) | 2018-11-30 | 2019-12-02 | Placenta-derived allogeneic car-t cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513164A JP2022513164A (ja) | 2022-02-07 |
| JP2022513164A5 true JP2022513164A5 (https=) | 2022-12-19 |
Family
ID=69005946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531011A Pending JP2022513164A (ja) | 2018-11-30 | 2019-12-02 | 胎盤由来同種ｃａｒ－ｔ細胞およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220118014A1 (https=) |
| EP (1) | EP3886876A1 (https=) |
| JP (1) | JP2022513164A (https=) |
| KR (1) | KR20210111244A (https=) |
| CN (1) | CN113395972A (https=) |
| AU (1) | AU2019387571A1 (https=) |
| BR (1) | BR112021010132A2 (https=) |
| CA (1) | CA3120364A1 (https=) |
| MX (1) | MX2021006402A (https=) |
| PH (1) | PH12021551246A1 (https=) |
| SG (1) | SG11202105217RA (https=) |
| WO (1) | WO2020113234A1 (https=) |
| ZA (1) | ZA202103263B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293462A (en) * | 2019-12-04 | 2022-07-01 | Celularity Inc | Placenta-derived allogeneic car-t cells and uses thereof |
| JP7846667B2 (ja) | 2020-07-16 | 2026-04-15 | レジェンド バイオテック アイルランド リミテッド | Ｃｄ２０結合分子及びその使用 |
| IL299867A (en) * | 2020-07-16 | 2023-03-01 | Nanjing Legend Biotech Co Ltd | Cd19 binding molecules and uses thereof |
| US20250290039A1 (en) * | 2023-07-10 | 2025-09-18 | Pluri Biotech Ltd. | Genetically engineered placental mucosalassociated invariant t (mait) cells and uses thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| EP2023717B1 (en) * | 2006-05-11 | 2016-04-13 | Anthrogenesis Corporation | Methods for collecting placenta cord blood stem cells |
| EP3783098A1 (en) * | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CN105916521A (zh) * | 2013-11-15 | 2016-08-31 | 人类起源公司 | 包含人胎盘灌注液细胞、其亚群的组合物及其用途 |
| US10611837B2 (en) * | 2014-04-10 | 2020-04-07 | Seattle Children's Hospital | Transgene genetic tags and methods of use |
| AU2015317316A1 (en) * | 2014-09-19 | 2017-04-06 | City Of Hope | Central memory T cells for adoptive T cell therapy |
| US10201606B2 (en) * | 2014-11-26 | 2019-02-12 | Miltenyi Biotec Gmbh | Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases |
| HRP20191873T1 (hr) * | 2014-12-12 | 2020-01-24 | Bluebird Bio, Inc. | Kimerni antigenski receptori |
| JP6797803B2 (ja) * | 2014-12-31 | 2020-12-09 | セルジーン コーポレイション | ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法 |
| US20160228547A1 (en) * | 2015-02-06 | 2016-08-11 | Batu Biologics, Inc. | Chimeric antigen receptor targeting of tumor endothelium |
| US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
| AU2016249005B2 (en) * | 2015-04-17 | 2022-06-16 | Novartis Ag | Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells |
| MX2017015147A (es) * | 2015-05-26 | 2018-03-28 | Celularity Inc | Angiogenesis usando celulas madre de placenta estimuladas. |
| CA2992551A1 (en) * | 2015-07-21 | 2017-01-26 | Novartis Ag | Methods for improving the efficacy and expansion of immune cells |
| AU2016323985B2 (en) * | 2015-09-17 | 2022-12-15 | Novartis Ag | CAR T cell therapies with enhanced efficacy |
| CN105331585A (zh) * | 2015-11-13 | 2016-02-17 | 科济生物医药（上海）有限公司 | 携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 |
| JP7123794B2 (ja) * | 2015-12-09 | 2022-08-23 | メモリアル スローン ケタリング キャンサー センター | 免疫細胞組成物及びそれを使用する方法 |
| US20200087681A1 (en) * | 2016-12-21 | 2020-03-19 | Ucl Business Plc | Therapeutic cells |
-
2019
- 2019-12-02 KR KR1020217016359A patent/KR20210111244A/ko not_active Ceased
- 2019-12-02 BR BR112021010132-2A patent/BR112021010132A2/pt not_active IP Right Cessation
- 2019-12-02 CN CN201980078364.2A patent/CN113395972A/zh active Pending
- 2019-12-02 EP EP19828010.9A patent/EP3886876A1/en not_active Withdrawn
- 2019-12-02 US US17/309,451 patent/US20220118014A1/en active Pending
- 2019-12-02 WO PCT/US2019/064074 patent/WO2020113234A1/en not_active Ceased
- 2019-12-02 MX MX2021006402A patent/MX2021006402A/es unknown
- 2019-12-02 AU AU2019387571A patent/AU2019387571A1/en not_active Abandoned
- 2019-12-02 CA CA3120364A patent/CA3120364A1/en active Pending
- 2019-12-02 SG SG11202105217RA patent/SG11202105217RA/en unknown
- 2019-12-02 JP JP2021531011A patent/JP2022513164A/ja active Pending
-
2021
- 2021-05-13 ZA ZA2021/03263A patent/ZA202103263B/en unknown
- 2021-05-28 PH PH12021551246A patent/PH12021551246A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | CD3+ CD4-CD8-(Double-negative) T cells in inflammation, immune disorders and cancer | |
| JP2022513164A5 (https=) | ||
| Leung | Use of NK cell activity in cure by transplant | |
| Abel et al. | Natural killer cells: development, maturation, and clinical utilization | |
| Mehta et al. | Cord blood as a source of natural killer cells | |
| Zeng et al. | Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance | |
| US20210228632A1 (en) | Compostion for use in immunotherapy | |
| Cerwenka et al. | Natural killer cell memory in infection, inflammation and cancer | |
| Ni et al. | Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors | |
| Oevermann et al. | Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation | |
| Della Chiesa et al. | Impact of HCMV infection on NK cell development and function after HSCT | |
| WO2012156958A4 (en) | Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof | |
| Lysakova-Devine et al. | Tissue-specific NK cell populations and their origin | |
| JP5118624B2 (ja) | 新規なヒトｔ細胞集団 | |
| JP2016539929A5 (https=) | ||
| Babor et al. | The role of KIR genes and ligands in leukemia surveillance | |
| Kwak et al. | Insights into myeloid-derived suppressor cells in inflammatory diseases | |
| Bhat et al. | Emerging role of natural killer cells in oncolytic virotherapy | |
| Parisi et al. | The more, the better:“do the right thing” for natural killer immunotherapy in acute myeloid leukemia | |
| JP2018531016A5 (https=) | ||
| Biondi et al. | Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia | |
| Choi et al. | The function of memory CD8+ T cells in immunotherapy for human diseases | |
| JP2013536232A5 (https=) | ||
| JP2008507961A5 (https=) | ||
| Fernandez et al. | Peripheral NKT cells in simian immunodeficiency virus-infected macaques |